Unlock more guides and resources
What Epidemiological Research Shows
Large reviews and public-health guidance associate time spent in damp or moldy buildings with respiratory symptoms, allergies, asthma problems, hypersensitivity pneumonitis, and eczema. These are epidemiological associations: they do not establish that mold caused one person's symptoms.
CDC and NIOSH summarize associations with asthma development and exacerbation, wheeze, cough, allergic rhinitis, hypersensitivity pneumonitis, and other symptoms. A damp building can also contain bacteria, dust mites, particles from wet materials, ventilation problems, and other irritants, so studies often cannot identify one responsible exposure.
CDC notes that damp and moldy environments may cause health effects or none at all, depending on the person and circumstances. Understanding what causes mold to grow is still essential for addressing the building conditions.
Mold Allergy Symptoms
Mold allergy triggers an immune response similar to other airborne allergies like pollen or pet dander. When mold spores are inhaled, the immune system may produce immunoglobulin E (IgE) antibodies, which trigger histamine release and cause allergic symptoms.
Common mold allergy symptoms include: runny or stuffy nose, sneezing, itchy or watery eyes, itchy throat and nose, postnasal drip, cough, and dry, itchy skin.
Symptoms can range from mild to severe and may be seasonal from outdoor mold peaks or year-round when indoor mold is present. Allergy testing can identify mold sensitization in some people, but a positive allergy test does not measure the mold level in a building.
Different common indoor mold species can trigger allergic reactions, and you do not need to identify the specific species to take action.
The Asthma Connection
The relationship between damp buildings and asthma is one of the most studied connections. Mold or other exposures in a damp building can trigger symptoms for some people with asthma, and studies associate damp indoor spaces with asthma development in some settings.
The WHO concluded there is "sufficient epidemiological evidence" of an association between indoor dampness-related factors and: asthma development in previously healthy individuals, asthma exacerbation (worsening of existing asthma), and current asthma symptoms.
Children may be particularly affected, as noted in our guide to vulnerable populations. Individual risk depends on health history, sensitization, the building, and other exposures; a building observation cannot predict who will develop asthma.
Mold is recognized as one of the common asthma triggers alongside dust mites, pet dander, and secondhand smoke.
Other Respiratory Effects
Beyond allergies and asthma, research has documented associations with other respiratory conditions:
Hypersensitivity pneumonitis is a rare but serious immune-mediated lung condition associated with inhaled fungi and other substances. Symptoms can include cough, shortness of breath, chills, fever, night sweats, or fatigue; timing and severity vary, so diagnosis requires medical evaluation.
Respiratory infections are reported in damp-building studies, but those associations do not show that mold caused an infection in a specific person or that altered immune function explains the finding. CDC notes that people with weakened immune systems or chronic lung disease may get lung infections from mold; this is a medical risk to discuss with a clinician, not a conclusion from a building observation.
Bronchitis symptoms and upper-airway irritation are also reported in damp-building studies, but symptoms have many possible causes and the studies do not isolate one exposure.
Chronic rhinosinusitis involves prolonged sinus inflammation and has many possible causes. A clinician should evaluate persistent or severe sinus symptoms rather than assuming that a damp building establishes fungal causation.
If you experience any of these conditions, review our guide on when to see a doctor for guidance on seeking appropriate medical care.
How Mold Affects Airways
Several pathways may contribute to symptoms, but a person's symptoms cannot identify which pathway or exposure is responsible.
Allergic response: In a person who is sensitized, inhaled mold can trigger an allergic response involving IgE antibodies, histamine, and inflammation in the airways or nasal passages.
Odor and irritation: Some molds release microbial volatile organic compounds (mVOCs) that contribute to a musty odor. EPA says the health effects of inhaling mVOCs are largely unknown and that more research is needed for non-occupational indoor exposure. A musty smell suggests mold growth should be investigated, but it does not prove what caused a symptom.
Other building exposures: Mold particles, fragments, and components such as beta-glucans are among the factors being studied, alongside bacteria, dust, chemicals, and other irritants found in damp buildings. Their presence does not establish a specific mechanism or diagnosis.
The wide variety of health effects cannot be explained by a single mechanism. Clinical evaluation and building investigation should keep multiple possible causes in view.
WHO Guidelines: Key Recommendations
The World Health Organization's Guidelines for Indoor Air Quality (2009) represent the most comprehensive international review of mold health effects. Key conclusions include:
Indoor dampness and mold consistently associate with respiratory symptoms, infections, and asthma. The most important way to avoid adverse health effects is preventing or minimizing persistent dampness and microbial growth on interior surfaces. No safe threshold level for mold exposure has been established, so major mold contamination should be addressed rather than measured indefinitely.
The WHO recommends addressing dampness and mold as a building health issue rather than focusing on specific mold species or toxins. Proper humidity control is the foundation of effective prevention.
Official Resources
This information is based on published research and official health guidelines. It is not medical advice. Consult a healthcare provider for personal health concerns.